← Back to Screener
Oaktree Acquisition Corp. III Life Sciences Unit (OACCU)
Price$10.68
Favorite Metrics
Price vs S&P 500 (26W)-4.64%
Price vs S&P 500 (4W)-8.05%
Market Capitalization$262.54M
All Metrics
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-2.34%
10-Day Avg Trading Volume0.03M
Quick Ratio (Quarterly)1.09x
3-Month Avg Trading Volume0.04M
52-Week High$10.74
26-Week Price Return2.25%
13-Week Price Return1.04%
Current Ratio (Quarterly)1.09x
3-Month Return Std Dev5.95%
Year-to-Date Return0.95%
5-Day Price Return0.75%
Month-to-Date Return0.95%
Price vs S&P 500 (13W)-1.34%
Beta0.08x
52-Week Low$10.04
Industry Peers — Blank Checks / SPACs(334)
| Symbol | P/E Ratio (Annual) | Indicated Dividend Yield (Annual) | ROE (TTM) | P/B Ratio (Quarterly) | Price |
|---|---|---|---|---|---|
OACCUOaktree Acquisition Corp. III Life Sciences Unit | — | — | — | — | $10.68 |
LFACLeapfrog Acquisition Corporation Class A Ordinary Shares | 742.60x | — | 1.92% | 2.80x | $9.95 |
LFACULeapfrog Acquisition Corporation Units | 720.81x | — | 1.92% | 2.80x | $10.04 |
AACIArmada Acquisition Corp. III Class A Ordinary Share | — | — | -9.52% | 14.61x | $9.90 |
BEAGBold Eagle Acquisition Corp. Class A Ordinary Shares | 61.97x | — | 3.80% | 2.33x | $10.53 |
BEAGRBold Eagle Acquisition Corp. Right | 61.97x | — | 3.80% | 2.33x | $0.24 |
BEAGUBold Eagle Acquisition Corp. Units | 61.97x | — | 3.80% | 2.33x | $10.74 |
BCSSBain Capital GSS Investment Corp. | 139.43x | — | — | 1.31x | $10.18 |
BCSS.UBain Capital GSS Investment Corp. Units, each consisting of one Class A Ordinary Share and one-fifth of one redeemable warrant | 139.43x | — | — | 1.31x | $10.39 |
CEPFCantor Equity Partners IV, Inc. Class A Ordinary Shares | 95.72x | — | — | 1.29x | $10.26 |
KRSPRice Acquisition Corporation 3 | 172.51x | — | — | 1.41x | $10.30 |
About
Oaktree Acquisition Corp III Life Sciences is a special purpose acquisition company (SPAC) established to identify and acquire a life sciences company. The company seeks to combine with an operating business in the healthcare or life sciences sector through a merger or similar business combination. As a SPAC, it operates without current business operations pending the completion of a qualifying acquisition.